Literature DB >> 12680769

Structural and functional analysis of caspase active sites.

David Chéreau1, Lalitha Kodandapani, Kevin J Tomaselli, Alfred P Spada, Joe C Wu.   

Abstract

Amino acid sequences of caspases 1, 3, 7, and 8 were aligned with their published three-dimensional (3D) structures. The resultant alignment was used as a template to compare the primary structures of caspases 2, 4-6, and 9-11 to build 3D homology models. The structural models were subsequently refined and validated using structure-activity relationship data obtained from an array of substrate-like inhibitors. All caspases were shown to have identical S1 and catalytic dyad architecture but diverse S2-S4 structures. S2 pockets of these 11 caspases can be briefly categorized into two groups: Csp3, -6, and -7 as one and Csp1, -2, -4, -5, -8, -9, -10, and -11 as the other. S2 pockets of Csp3, -6, and -7 are smaller than those of the other eight caspases, and are limited to binding small P2 residues such as Ala and Val. At the S3 site, the presence of a conserved Arg in all caspases suggests that Glu would be a universally preferred P3 residue. Csp8 and Csp9 have an additional Arg in this pocket that can further enhance the binding of a P3 Glu, whereas Csp2 has a Glu adjacent to the conserved Arg. As such, Csp2 is the only caspase that can accommodate both positively and negatively charged P3. At S4, Csp1, -4, -5, and -11 are closely related with respect to their structures and binder preferences; all have a large hydrophobic pocket and prefer large hydrophobic residues such as Trp. S4 of Csp2, -3, and -7 represents an opposite group with a conformation that is highly specific in binding an Asp. The S4 structures of Csp6, -8, -9, and -10 appear to be hybrids of the two extremes, and have little specificity for any P4. Information revealed from this work provides a guide for designing potent caspase inhibitors with desirable specificity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12680769     DOI: 10.1021/bi020593l

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

Review 1.  The protein structures that shape caspase activity, specificity, activation and inhibition.

Authors:  Pablo Fuentes-Prior; Guy S Salvesen
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

2.  Functional interplay between caspase cleavage and phosphorylation sculpts the apoptotic proteome.

Authors:  Melissa M Dix; Gabriel M Simon; Chu Wang; Eric Okerberg; Matthew P Patricelli; Benjamin F Cravatt
Journal:  Cell       Date:  2012-07-20       Impact factor: 41.582

3.  Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease.

Authors:  Yunxia Tao; Jun Kim; Sarah Faubel; Joe C Wu; Sandor A Falk; Robert W Schrier; Charles L Edelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-29       Impact factor: 11.205

4.  Substrate-induced conformational changes occur in all cleaved forms of caspase-6.

Authors:  Sravanti Vaidya; Elih M Velázquez-Delgado; Genevieve Abbruzzese; Jeanne A Hardy
Journal:  J Mol Biol       Date:  2010-11-25       Impact factor: 5.469

5.  A Huntingtin-based peptide inhibitor of caspase-6 provides protection from mutant Huntingtin-induced motor and behavioral deficits.

Authors:  Israel Aharony; Dagmar E Ehrnhoefer; Adi Shruster; Xiaofan Qiu; Sonia Franciosi; Michael R Hayden; Daniel Offen
Journal:  Hum Mol Genet       Date:  2015-01-23       Impact factor: 6.150

6.  Mutation analysis of carbamoyl phosphate synthetase: does the structurally conserved glutamine amidotransferase triad act as a functional dyad?

Authors:  Emily J Hart; Susan G Powers-Lee
Journal:  Protein Sci       Date:  2008-05-05       Impact factor: 6.725

7.  Dissecting an allosteric switch in caspase-7 using chemical and mutational probes.

Authors:  Jeanne A Hardy; James A Wells
Journal:  J Biol Chem       Date:  2009-07-06       Impact factor: 5.157

8.  Structure-Based Design and Biological Evaluation of Novel Caspase-2 Inhibitors Based on the Peptide AcVDVAD-CHO and the Caspase-2-Mediated Tau Cleavage Sequence YKPVD314.

Authors:  Merlin Bresinsky; Jessica M Strasser; Bernadette Vallaster; Peng Liu; William M McCue; Jessica Fuller; Alexander Hubmann; Gurpreet Singh; Kathryn M Nelson; Matthew E Cuellar; Carrie M Wilmot; Barry C Finzel; Karen H Ashe; Michael A Walters; Steffen Pockes
Journal:  ACS Pharmacol Transl Sci       Date:  2022-01-05

Review 9.  BH3-Only Proteins Noxa and Puma Are Key Regulators of Induced Apoptosis.

Authors:  Rabih Roufayel; Khaled Younes; Ahmed Al-Sabi; Nimer Murshid
Journal:  Life (Basel)       Date:  2022-02-09

10.  In vivo imaging of hierarchical spatiotemporal activation of caspase-8 during apoptosis.

Authors:  Katsuya Kominami; Takeharu Nagai; Tatsuya Sawasaki; Yuki Tsujimura; Kenta Yashima; Yasuhiro Sunaga; Masateru Tsuchimochi; Jun Nishimura; Kumiko Chiba; Jun Nakabayashi; Koji Koyamada; Yaeta Endo; Hideo Yokota; Atsushi Miyawaki; Noboru Manabe; Kazuhiro Sakamaki
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.